Global Non-opioid Pain Patch Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Non-opioid Pain Patch Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Non-opioid Pain Patch by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Non-opioid Pain Patch by Country/Region, 2017, 2022 & 2028

2.2 Non-opioid Pain Patch Segment by Type

2.2.1 Lidocaine Patches

2.2.2 Diclofenac Patches

2.2.3 Indomethacin Patches

2.2.4 Counter-Irritant Patches

2.2.5 Fentanyl Patches

2.2.6 Others

2.3 Non-opioid Pain Patch Sales by Type

2.3.1 Global Non-opioid Pain Patch Sales Market Share by Type (2017-2022)

2.3.2 Global Non-opioid Pain Patch Revenue and Market Share by Type (2017-2022)

2.3.3 Global Non-opioid Pain Patch Sale Price by Type (2017-2022)

2.4 Non-opioid Pain Patch Segment by Application

2.4.1 OTC

2.4.2 Rx

2.5 Non-opioid Pain Patch Sales by Application

2.5.1 Global Non-opioid Pain Patch Sale Market Share by Application (2017-2022)

2.5.2 Global Non-opioid Pain Patch Revenue and Market Share by Application (2017-2022)

2.5.3 Global Non-opioid Pain Patch Sale Price by Application (2017-2022)

3 Global Non-opioid Pain Patch by Company

3.1 Global Non-opioid Pain Patch Breakdown Data by Company

3.1.1 Global Non-opioid Pain Patch Annual Sales by Company (2020-2022)

3.1.2 Global Non-opioid Pain Patch Sales Market Share by Company (2020-2022)

3.2 Global Non-opioid Pain Patch Annual Revenue by Company (2020-2022)

3.2.1 Global Non-opioid Pain Patch Revenue by Company (2020-2022)

3.2.2 Global Non-opioid Pain Patch Revenue Market Share by Company (2020-2022)

3.3 Global Non-opioid Pain Patch Sale Price by Company

3.4 Key Manufacturers Non-opioid Pain Patch Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Non-opioid Pain Patch Product Location Distribution

3.4.2 Players Non-opioid Pain Patch Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Non-opioid Pain Patch by Geographic Region

4.1 World Historic Non-opioid Pain Patch Market Size by Geographic Region (2017-2022)

4.1.1 Global Non-opioid Pain Patch Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Non-opioid Pain Patch Annual Revenue by Geographic Region

4.2 World Historic Non-opioid Pain Patch Market Size by Country/Region (2017-2022)

4.2.1 Global Non-opioid Pain Patch Annual Sales by Country/Region (2017-2022)

4.2.2 Global Non-opioid Pain Patch Annual Revenue by Country/Region

4.3 Americas Non-opioid Pain Patch Sales Growth

4.4 APAC Non-opioid Pain Patch Sales Growth

4.5 Europe Non-opioid Pain Patch Sales Growth

4.6 Middle East & Africa Non-opioid Pain Patch Sales Growth

5 Americas

5.1 Americas Non-opioid Pain Patch Sales by Country

5.1.1 Americas Non-opioid Pain Patch Sales by Country (2017-2022)

5.1.2 Americas Non-opioid Pain Patch Revenue by Country (2017-2022)

5.2 Americas Non-opioid Pain Patch Sales by Type

5.3 Americas Non-opioid Pain Patch Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Non-opioid Pain Patch Sales by Region

6.1.1 APAC Non-opioid Pain Patch Sales by Region (2017-2022)

6.1.2 APAC Non-opioid Pain Patch Revenue by Region (2017-2022)

6.2 APAC Non-opioid Pain Patch Sales by Type

6.3 APAC Non-opioid Pain Patch Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Non-opioid Pain Patch by Country

7.1.1 Europe Non-opioid Pain Patch Sales by Country (2017-2022)

7.1.2 Europe Non-opioid Pain Patch Revenue by Country (2017-2022)

7.2 Europe Non-opioid Pain Patch Sales by Type

7.3 Europe Non-opioid Pain Patch Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Non-opioid Pain Patch by Country

8.1.1 Middle East & Africa Non-opioid Pain Patch Sales by Country (2017-2022)

8.1.2 Middle East & Africa Non-opioid Pain Patch Revenue by Country (2017-2022)

8.2 Middle East & Africa Non-opioid Pain Patch Sales by Type

8.3 Middle East & Africa Non-opioid Pain Patch Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Non-opioid Pain Patch

10.3 Manufacturing Process Analysis of Non-opioid Pain Patch

10.4 Industry Chain Structure of Non-opioid Pain Patch

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Non-opioid Pain Patch Distributors

11.3 Non-opioid Pain Patch Customer

12 World Forecast Review for Non-opioid Pain Patch by Geographic Region

12.1 Global Non-opioid Pain Patch Market Size Forecast by Region

12.1.1 Global Non-opioid Pain Patch Forecast by Region (2023-2028)

12.1.2 Global Non-opioid Pain Patch Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Non-opioid Pain Patch Forecast by Type

12.7 Global Non-opioid Pain Patch Forecast by Application

13 Key Players Analysis

13.1 Hisamitsu

13.1.1 Hisamitsu Company Information

13.1.2 Hisamitsu Non-opioid Pain Patch Product Offered

13.1.3 Hisamitsu Non-opioid Pain Patch Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Hisamitsu Main Business Overview

13.1.5 Hisamitsu Latest Developments

13.2 Mylan

13.2.1 Mylan Company Information

13.2.2 Mylan Non-opioid Pain Patch Product Offered

13.2.3 Mylan Non-opioid Pain Patch Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Mylan Main Business Overview

13.2.5 Mylan Latest Developments

13.3 Johnson & Johnson

13.3.1 Johnson & Johnson Company Information

13.3.2 Johnson & Johnson Non-opioid Pain Patch Product Offered

13.3.3 Johnson & Johnson Non-opioid Pain Patch Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Johnson & Johnson Main Business Overview

13.3.5 Johnson & Johnson Latest Developments

13.4 Actavis

13.4.1 Actavis Company Information

13.4.2 Actavis Non-opioid Pain Patch Product Offered

13.4.3 Actavis Non-opioid Pain Patch Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Actavis Main Business Overview

13.4.5 Actavis Latest Developments

13.5 Lingrui

13.5.1 Lingrui Company Information

13.5.2 Lingrui Non-opioid Pain Patch Product Offered

13.5.3 Lingrui Non-opioid Pain Patch Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Lingrui Main Business Overview

13.5.5 Lingrui Latest Developments

13.6 Teikoku Seiyaku

13.6.1 Teikoku Seiyaku Company Information

13.6.2 Teikoku Seiyaku Non-opioid Pain Patch Product Offered

13.6.3 Teikoku Seiyaku Non-opioid Pain Patch Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Teikoku Seiyaku Main Business Overview

13.6.5 Teikoku Seiyaku Latest Developments

13.7 Sanofi

13.7.1 Sanofi Company Information

13.7.2 Sanofi Non-opioid Pain Patch Product Offered

13.7.3 Sanofi Non-opioid Pain Patch Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Sanofi Main Business Overview

13.7.5 Sanofi Latest Developments

13.8 Novartis

13.8.1 Novartis Company Information

13.8.2 Novartis Non-opioid Pain Patch Product Offered

13.8.3 Novartis Non-opioid Pain Patch Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Novartis Main Business Overview

13.8.5 Novartis Latest Developments

13.9 Qizheng

13.9.1 Qizheng Company Information

13.9.2 Qizheng Non-opioid Pain Patch Product Offered

13.9.3 Qizheng Non-opioid Pain Patch Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Qizheng Main Business Overview

13.9.5 Qizheng Latest Developments

13.10 Endo

13.10.1 Endo Company Information

13.10.2 Endo Non-opioid Pain Patch Product Offered

13.10.3 Endo Non-opioid Pain Patch Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Endo Main Business Overview

13.10.5 Endo Latest Developments

13.11 Huarun 999

13.11.1 Huarun 999 Company Information

13.11.2 Huarun 999 Non-opioid Pain Patch Product Offered

13.11.3 Huarun 999 Non-opioid Pain Patch Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Huarun 999 Main Business Overview

13.11.5 Huarun 999 Latest Developments

13.12 GSK

13.12.1 GSK Company Information

13.12.2 GSK Non-opioid Pain Patch Product Offered

13.12.3 GSK Non-opioid Pain Patch Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 GSK Main Business Overview

13.12.5 GSK Latest Developments

13.13 Haw Par

13.13.1 Haw Par Company Information

13.13.2 Haw Par Non-opioid Pain Patch Product Offered

13.13.3 Haw Par Non-opioid Pain Patch Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Haw Par Main Business Overview

13.13.5 Haw Par Latest Developments

13.14 Nichiban

13.14.1 Nichiban Company Information

13.14.2 Nichiban Non-opioid Pain Patch Product Offered

13.14.3 Nichiban Non-opioid Pain Patch Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Nichiban Main Business Overview

13.14.5 Nichiban Latest Developments

13.15 Mentholatum

13.15.1 Mentholatum Company Information

13.15.2 Mentholatum Non-opioid Pain Patch Product Offered

13.15.3 Mentholatum Non-opioid Pain Patch Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 Mentholatum Main Business Overview

13.15.5 Mentholatum Latest Developments

13.16 Laboratoires Genevrier

13.16.1 Laboratoires Genevrier Company Information

13.16.2 Laboratoires Genevrier Non-opioid Pain Patch Product Offered

13.16.3 Laboratoires Genevrier Non-opioid Pain Patch Sales, Revenue, Price and Gross Margin (2020-2022)

13.16.4 Laboratoires Genevrier Main Business Overview

13.16.5 Laboratoires Genevrier Latest Developments

13.17 BLUE-EMU

13.17.1 BLUE-EMU Company Information

13.17.2 BLUE-EMU Non-opioid Pain Patch Product Offered

13.17.3 BLUE-EMU Non-opioid Pain Patch Sales, Revenue, Price and Gross Margin (2020-2022)

13.17.4 BLUE-EMU Main Business Overview

13.17.5 BLUE-EMU Latest Developments

14 Research Findings and Conclusion

Table 1. Non-opioid Pain Patch Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Non-opioid Pain Patch Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Lidocaine Patches

Table 4. Major Players of Diclofenac Patches

Table 5. Major Players of Indomethacin Patches

Table 6. Major Players of Counter-Irritant Patches

Table 7. Major Players of Fentanyl Patches

Table 8. Major Players of Others

Table 9. Global Non-opioid Pain Patch Sales by Type (2017-2022) & (M Units)

Table 10. Global Non-opioid Pain Patch Sales Market Share by Type (2017-2022)

Table 11. Global Non-opioid Pain Patch Revenue by Type (2017-2022) & ($ million)

Table 12. Global Non-opioid Pain Patch Revenue Market Share by Type (2017-2022)

Table 13. Global Non-opioid Pain Patch Sale Price by Type (2017-2022) & (USD/K Units)

Table 14. Global Non-opioid Pain Patch Sales by Application (2017-2022) & (M Units)

Table 15. Global Non-opioid Pain Patch Sales Market Share by Application (2017-2022)

Table 16. Global Non-opioid Pain Patch Revenue by Application (2017-2022)

Table 17. Global Non-opioid Pain Patch Revenue Market Share by Application (2017-2022)

Table 18. Global Non-opioid Pain Patch Sale Price by Application (2017-2022) & (USD/K Units)

Table 19. Global Non-opioid Pain Patch Sales by Company (2020-2022) & (M Units)

Table 20. Global Non-opioid Pain Patch Sales Market Share by Company (2020-2022)

Table 21. Global Non-opioid Pain Patch Revenue by Company (2020-2022) ($ Millions)

Table 22. Global Non-opioid Pain Patch Revenue Market Share by Company (2020-2022)

Table 23. Global Non-opioid Pain Patch Sale Price by Company (2020-2022) & (USD/K Units)

Table 24. Key Manufacturers Non-opioid Pain Patch Producing Area Distribution and Sales Area

Table 25. Players Non-opioid Pain Patch Products Offered

Table 26. Non-opioid Pain Patch Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 27. New Products and Potential Entrants

Table 28. Mergers & Acquisitions, Expansion

Table 29. Global Non-opioid Pain Patch Sales by Geographic Region (2017-2022) & (M Units)

Table 30. Global Non-opioid Pain Patch Sales Market Share Geographic Region (2017-2022)

Table 31. Global Non-opioid Pain Patch Revenue by Geographic Region (2017-2022) & ($ millions)

Table 32. Global Non-opioid Pain Patch Revenue Market Share by Geographic Region (2017-2022)

Table 33. Global Non-opioid Pain Patch Sales by Country/Region (2017-2022) & (M Units)

Table 34. Global Non-opioid Pain Patch Sales Market Share by Country/Region (2017-2022)

Table 35. Global Non-opioid Pain Patch Revenue by Country/Region (2017-2022) & ($ millions)

Table 36. Global Non-opioid Pain Patch Revenue Market Share by Country/Region (2017-2022)

Table 37. Americas Non-opioid Pain Patch Sales by Country (2017-2022) & (M Units)

Table 38. Americas Non-opioid Pain Patch Sales Market Share by Country (2017-2022)

Table 39. Americas Non-opioid Pain Patch Revenue by Country (2017-2022) & ($ Millions)

Table 40. Americas Non-opioid Pain Patch Revenue Market Share by Country (2017-2022)

Table 41. Americas Non-opioid Pain Patch Sales by Type (2017-2022) & (M Units)

Table 42. Americas Non-opioid Pain Patch Sales Market Share by Type (2017-2022)

Table 43. Americas Non-opioid Pain Patch Sales by Application (2017-2022) & (M Units)

Table 44. Americas Non-opioid Pain Patch Sales Market Share by Application (2017-2022)

Table 45. APAC Non-opioid Pain Patch Sales by Region (2017-2022) & (M Units)

Table 46. APAC Non-opioid Pain Patch Sales Market Share by Region (2017-2022)

Table 47. APAC Non-opioid Pain Patch Revenue by Region (2017-2022) & ($ Millions)

Table 48. APAC Non-opioid Pain Patch Revenue Market Share by Region (2017-2022)

Table 49. APAC Non-opioid Pain Patch Sales by Type (2017-2022) & (M Units)

Table 50. APAC Non-opioid Pain Patch Sales Market Share by Type (2017-2022)

Table 51. APAC Non-opioid Pain Patch Sales by Application (2017-2022) & (M Units)

Table 52. APAC Non-opioid Pain Patch Sales Market Share by Application (2017-2022)

Table 53. Europe Non-opioid Pain Patch Sales by Country (2017-2022) & (M Units)

Table 54. Europe Non-opioid Pain Patch Sales Market Share by Country (2017-2022)

Table 55. Europe Non-opioid Pain Patch Revenue by Country (2017-2022) & ($ Millions)

Table 56. Europe Non-opioid Pain Patch Revenue Market Share by Country (2017-2022)

Table 57. Europe Non-opioid Pain Patch Sales by Type (2017-2022) & (M Units)

Table 58. Europe Non-opioid Pain Patch Sales Market Share by Type (2017-2022)

Table 59. Europe Non-opioid Pain Patch Sales by Application (2017-2022) & (M Units)

Table 60. Europe Non-opioid Pain Patch Sales Market Share by Application (2017-2022)

Table 61. Middle East & Africa Non-opioid Pain Patch Sales by Country (2017-2022) & (M Units)

Table 62. Middle East & Africa Non-opioid Pain Patch Sales Market Share by Country (2017-2022)

Table 63. Middle East & Africa Non-opioid Pain Patch Revenue by Country (2017-2022) & ($ Millions)

Table 64. Middle East & Africa Non-opioid Pain Patch Revenue Market Share by Country (2017-2022)

Table 65. Middle East & Africa Non-opioid Pain Patch Sales by Type (2017-2022) & (M Units)

Table 66. Middle East & Africa Non-opioid Pain Patch Sales Market Share by Type (2017-2022)

Table 67. Middle East & Africa Non-opioid Pain Patch Sales by Application (2017-2022) & (M Units)

Table 68. Middle East & Africa Non-opioid Pain Patch Sales Market Share by Application (2017-2022)

Table 69. Key Market Drivers & Growth Opportunities of Non-opioid Pain Patch

Table 70. Key Market Challenges & Risks of Non-opioid Pain Patch

Table 71. Key Industry Trends of Non-opioid Pain Patch

Table 72. Non-opioid Pain Patch Raw Material

Table 73. Key Suppliers of Raw Materials

Table 74. Non-opioid Pain Patch Distributors List

Table 75. Non-opioid Pain Patch Customer List

Table 76. Global Non-opioid Pain Patch Sales Forecast by Region (2023-2028) & (M Units)

Table 77. Global Non-opioid Pain Patch Sales Market Forecast by Region

Table 78. Global Non-opioid Pain Patch Revenue Forecast by Region (2023-2028) & ($ millions)

Table 79. Global Non-opioid Pain Patch Revenue Market Share Forecast by Region (2023-2028)

Table 80. Americas Non-opioid Pain Patch Sales Forecast by Country (2023-2028) & (M Units)

Table 81. Americas Non-opioid Pain Patch Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. APAC Non-opioid Pain Patch Sales Forecast by Region (2023-2028) & (M Units)

Table 83. APAC Non-opioid Pain Patch Revenue Forecast by Region (2023-2028) & ($ millions)

Table 84. Europe Non-opioid Pain Patch Sales Forecast by Country (2023-2028) & (M Units)

Table 85. Europe Non-opioid Pain Patch Revenue Forecast by Country (2023-2028) & ($ millions)

Table 86. Middle East & Africa Non-opioid Pain Patch Sales Forecast by Country (2023-2028) & (M Units)

Table 87. Middle East & Africa Non-opioid Pain Patch Revenue Forecast by Country (2023-2028) & ($ millions)

Table 88. Global Non-opioid Pain Patch Sales Forecast by Type (2023-2028) & (M Units)

Table 89. Global Non-opioid Pain Patch Sales Market Share Forecast by Type (2023-2028)

Table 90. Global Non-opioid Pain Patch Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 91. Global Non-opioid Pain Patch Revenue Market Share Forecast by Type (2023-2028)

Table 92. Global Non-opioid Pain Patch Sales Forecast by Application (2023-2028) & (M Units)

Table 93. Global Non-opioid Pain Patch Sales Market Share Forecast by Application (2023-2028)

Table 94. Global Non-opioid Pain Patch Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 95. Global Non-opioid Pain Patch Revenue Market Share Forecast by Application (2023-2028)

Table 96. Hisamitsu Basic Information, Non-opioid Pain Patch Manufacturing Base, Sales Area and Its Competitors

Table 97. Hisamitsu Non-opioid Pain Patch Product Offered

Table 98. Hisamitsu Non-opioid Pain Patch Sales (M Units), Revenue ($ Million), Price (USD/K Units) and Gross Margin (2020-2022)

Table 99. Hisamitsu Main Business

Table 100. Hisamitsu Latest Developments

Table 101. Mylan Basic Information, Non-opioid Pain Patch Manufacturing Base, Sales Area and Its Competitors

Table 102. Mylan Non-opioid Pain Patch Product Offered

Table 103. Mylan Non-opioid Pain Patch Sales (M Units), Revenue ($ Million), Price (USD/K Units) and Gross Margin (2020-2022)

Table 104. Mylan Main Business

Table 105. Mylan Latest Developments

Table 106. Johnson & Johnson Basic Information, Non-opioid Pain Patch Manufacturing Base, Sales Area and Its Competitors

Table 107. Johnson & Johnson Non-opioid Pain Patch Product Offered

Table 108. Johnson & Johnson Non-opioid Pain Patch Sales (M Units), Revenue ($ Million), Price (USD/K Units) and Gross Margin (2020-2022)

Table 109. Johnson & Johnson Main Business

Table 110. Johnson & Johnson Latest Developments

Table 111. Actavis Basic Information, Non-opioid Pain Patch Manufacturing Base, Sales Area and Its Competitors

Table 112. Actavis Non-opioid Pain Patch Product Offered

Table 113. Actavis Non-opioid Pain Patch Sales (M Units), Revenue ($ Million), Price (USD/K Units) and Gross Margin (2020-2022)

Table 114. Actavis Main Business

Table 115. Actavis Latest Developments

Table 116. Lingrui Basic Information, Non-opioid Pain Patch Manufacturing Base, Sales Area and Its Competitors

Table 117. Lingrui Non-opioid Pain Patch Product Offered

Table 118. Lingrui Non-opioid Pain Patch Sales (M Units), Revenue ($ Million), Price (USD/K Units) and Gross Margin (2020-2022)

Table 119. Lingrui Main Business

Table 120. Lingrui Latest Developments

Table 121. Teikoku Seiyaku Basic Information, Non-opioid Pain Patch Manufacturing Base, Sales Area and Its Competitors

Table 122. Teikoku Seiyaku Non-opioid Pain Patch Product Offered

Table 123. Teikoku Seiyaku Non-opioid Pain Patch Sales (M Units), Revenue ($ Million), Price (USD/K Units) and Gross Margin (2020-2022)

Table 124. Teikoku Seiyaku Main Business

Table 125. Teikoku Seiyaku Latest Developments

Table 126. Sanofi Basic Information, Non-opioid Pain Patch Manufacturing Base, Sales Area and Its Competitors

Table 127. Sanofi Non-opioid Pain Patch Product Offered

Table 128. Sanofi Non-opioid Pain Patch Sales (M Units), Revenue ($ Million), Price (USD/K Units) and Gross Margin (2020-2022)

Table 129. Sanofi Main Business

Table 130. Sanofi Latest Developments

Table 131. Novartis Basic Information, Non-opioid Pain Patch Manufacturing Base, Sales Area and Its Competitors

Table 132. Novartis Non-opioid Pain Patch Product Offered

Table 133. Novartis Non-opioid Pain Patch Sales (M Units), Revenue ($ Million), Price (USD/K Units) and Gross Margin (2020-2022)

Table 134. Novartis Main Business

Table 135. Novartis Latest Developments

Table 136. Qizheng Basic Information, Non-opioid Pain Patch Manufacturing Base, Sales Area and Its Competitors

Table 137. Qizheng Non-opioid Pain Patch Product Offered

Table 138. Qizheng Non-opioid Pain Patch Sales (M Units), Revenue ($ Million), Price (USD/K Units) and Gross Margin (2020-2022)

Table 139. Qizheng Main Business

Table 140. Qizheng Latest Developments

Table 141. Endo Basic Information, Non-opioid Pain Patch Manufacturing Base, Sales Area and Its Competitors

Table 142. Endo Non-opioid Pain Patch Product Offered

Table 143. Endo Non-opioid Pain Patch Sales (M Units), Revenue ($ Million), Price (USD/K Units) and Gross Margin (2020-2022)

Table 144. Endo Main Business

Table 145. Endo Latest Developments

Table 146. Huarun 999 Basic Information, Non-opioid Pain Patch Manufacturing Base, Sales Area and Its Competitors

Table 147. Huarun 999 Non-opioid Pain Patch Product Offered

Table 148. Huarun 999 Non-opioid Pain Patch Sales (M Units), Revenue ($ Million), Price (USD/K Units) and Gross Margin (2020-2022)

Table 149. Huarun 999 Main Business

Table 150. Huarun 999 Latest Developments

Table 151. GSK Basic Information, Non-opioid Pain Patch Manufacturing Base, Sales Area and Its Competitors

Table 152. GSK Non-opioid Pain Patch Product Offered

Table 153. GSK Non-opioid Pain Patch Sales (M Units), Revenue ($ Million), Price (USD/K Units) and Gross Margin (2020-2022)

Table 154. GSK Main Business

Table 155. GSK Latest Developments

Table 156. Haw Par Basic Information, Non-opioid Pain Patch Manufacturing Base, Sales Area and Its Competitors

Table 157. Haw Par Non-opioid Pain Patch Product Offered

Table 158. Haw Par Non-opioid Pain Patch Sales (M Units), Revenue ($ Million), Price (USD/K Units) and Gross Margin (2020-2022)

Table 159. Haw Par Main Business

Table 160. Haw Par Latest Developments

Table 161. Nichiban Basic Information, Non-opioid Pain Patch Manufacturing Base, Sales Area and Its Competitors

Table 162. Nichiban Non-opioid Pain Patch Product Offered

Table 163. Nichiban Non-opioid Pain Patch Sales (M Units), Revenue ($ Million), Price (USD/K Units) and Gross Margin (2020-2022)

Table 164. Nichiban Main Business

Table 165. Nichiban Latest Developments

Table 166. Mentholatum Basic Information, Non-opioid Pain Patch Manufacturing Base, Sales Area and Its Competitors

Table 167. Mentholatum Non-opioid Pain Patch Product Offered

Table 168. Mentholatum Non-opioid Pain Patch Sales (M Units), Revenue ($ Million), Price (USD/K Units) and Gross Margin (2020-2022)

Table 169. Mentholatum Main Business

Table 170. Mentholatum Latest Developments

Table 171. Laboratoires Genevrier Basic Information, Non-opioid Pain Patch Manufacturing Base, Sales Area and Its Competitors

Table 172. Laboratoires Genevrier Non-opioid Pain Patch Product Offered

Table 173. Laboratoires Genevrier Non-opioid Pain Patch Sales (M Units), Revenue ($ Million), Price (USD/K Units) and Gross Margin (2020-2022)

Table 174. Laboratoires Genevrier Main Business

Table 175. Laboratoires Genevrier Latest Developments

Table 176. BLUE-EMU Basic Information, Non-opioid Pain Patch Manufacturing Base, Sales Area and Its Competitors

Table 177. BLUE-EMU Non-opioid Pain Patch Product Offered

Table 178. BLUE-EMU Non-opioid Pain Patch Sales (M Units), Revenue ($ Million), Price (USD/K Units) and Gross Margin (2020-2022)

Table 179. BLUE-EMU Main Business

Table 180. BLUE-EMU Latest Developments

List of Figures

Figure 1. Picture of Non-opioid Pain Patch

Figure 2. Non-opioid Pain Patch Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Non-opioid Pain Patch Sales Growth Rate 2017-2028 (M Units)

Figure 7. Global Non-opioid Pain Patch Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Non-opioid Pain Patch Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Lidocaine Patches

Figure 10. Product Picture of Diclofenac Patches

Figure 11. Product Picture of Indomethacin Patches

Figure 12. Product Picture of Counter-Irritant Patches

Figure 13. Product Picture of Fentanyl Patches

Figure 14. Product Picture of Others

Figure 15. Global Non-opioid Pain Patch Sales Market Share by Type in 2021

Figure 16. Global Non-opioid Pain Patch Revenue Market Share by Type (2017-2022)

Figure 17. Non-opioid Pain Patch Consumed in OTC

Figure 18. Global Non-opioid Pain Patch Market: OTC (2017-2022) & (M Units)

Figure 19. Non-opioid Pain Patch Consumed in Rx

Figure 20. Global Non-opioid Pain Patch Market: Rx (2017-2022) & (M Units)

Figure 21. Global Non-opioid Pain Patch Sales Market Share by Application (2017-2022)

Figure 22. Global Non-opioid Pain Patch Revenue Market Share by Application in 2021

Figure 23. Non-opioid Pain Patch Revenue Market by Company in 2021 ($ Million)

Figure 24. Global Non-opioid Pain Patch Revenue Market Share by Company in 2021

Figure 25. Global Non-opioid Pain Patch Sales Market Share by Geographic Region (2017-2022)

Figure 26. Global Non-opioid Pain Patch Revenue Market Share by Geographic Region in 2021

Figure 27. Global Non-opioid Pain Patch Sales Market Share by Region (2017-2022)

Figure 28. Global Non-opioid Pain Patch Revenue Market Share by Country/Region in 2021

Figure 29. Americas Non-opioid Pain Patch Sales 2017-2022 (M Units)

Figure 30. Americas Non-opioid Pain Patch Revenue 2017-2022 ($ Millions)

Figure 31. APAC Non-opioid Pain Patch Sales 2017-2022 (M Units)

Figure 32. APAC Non-opioid Pain Patch Revenue 2017-2022 ($ Millions)

Figure 33. Europe Non-opioid Pain Patch Sales 2017-2022 (M Units)

Figure 34. Europe Non-opioid Pain Patch Revenue 2017-2022 ($ Millions)

Figure 35. Middle East & Africa Non-opioid Pain Patch Sales 2017-2022 (M Units)

Figure 36. Middle East & Africa Non-opioid Pain Patch Revenue 2017-2022 ($ Millions)

Figure 37. Americas Non-opioid Pain Patch Sales Market Share by Country in 2021

Figure 38. Americas Non-opioid Pain Patch Revenue Market Share by Country in 2021

Figure 39. United States Non-opioid Pain Patch Revenue Growth 2017-2022 ($ Millions)

Figure 40. Canada Non-opioid Pain Patch Revenue Growth 2017-2022 ($ Millions)

Figure 41. Mexico Non-opioid Pain Patch Revenue Growth 2017-2022 ($ Millions)

Figure 42. Brazil Non-opioid Pain Patch Revenue Growth 2017-2022 ($ Millions)

Figure 43. APAC Non-opioid Pain Patch Sales Market Share by Region in 2021

Figure 44. APAC Non-opioid Pain Patch Revenue Market Share by Regions in 2021

Figure 45. China Non-opioid Pain Patch Revenue Growth 2017-2022 ($ Millions)

Figure 46. Japan Non-opioid Pain Patch Revenue Growth 2017-2022 ($ Millions)

Figure 47. South Korea Non-opioid Pain Patch Revenue Growth 2017-2022 ($ Millions)

Figure 48. Southeast Asia Non-opioid Pain Patch Revenue Growth 2017-2022 ($ Millions)

Figure 49. India Non-opioid Pain Patch Revenue Growth 2017-2022 ($ Millions)

Figure 50. Australia Non-opioid Pain Patch Revenue Growth 2017-2022 ($ Millions)

Figure 51. Europe Non-opioid Pain Patch Sales Market Share by Country in 2021

Figure 52. Europe Non-opioid Pain Patch Revenue Market Share by Country in 2021

Figure 53. Germany Non-opioid Pain Patch Revenue Growth 2017-2022 ($ Millions)

Figure 54. France Non-opioid Pain Patch Revenue Growth 2017-2022 ($ Millions)

Figure 55. UK Non-opioid Pain Patch Revenue Growth 2017-2022 ($ Millions)

Figure 56. Italy Non-opioid Pain Patch Revenue Growth 2017-2022 ($ Millions)

Figure 57. Russia Non-opioid Pain Patch Revenue Growth 2017-2022 ($ Millions)

Figure 58. Middle East & Africa Non-opioid Pain Patch Sales Market Share by Country in 2021

Figure 59. Middle East & Africa Non-opioid Pain Patch Revenue Market Share by Country in 2021

Figure 60. Egypt Non-opioid Pain Patch Revenue Growth 2017-2022 ($ Millions)

Figure 61. South Africa Non-opioid Pain Patch Revenue Growth 2017-2022 ($ Millions)

Figure 62. Israel Non-opioid Pain Patch Revenue Growth 2017-2022 ($ Millions)

Figure 63. Turkey Non-opioid Pain Patch Revenue Growth 2017-2022 ($ Millions)

Figure 64. GCC Country Non-opioid Pain Patch Revenue Growth 2017-2022 ($ Millions)

Figure 65. Manufacturing Cost Structure Analysis of Non-opioid Pain Patch in 2021

Figure 66. Manufacturing Process Analysis of Non-opioid Pain Patch

Figure 67. Industry Chain Structure of Non-opioid Pain Patch

Figure 68. Channels of Distribution

Figure 69. Distributors Profiles